Credence Research Logo

Home » Healthcare » Pharmaceuticals » Hospital Infection Prevention And Control Market

Hospital Infection Prevention And Control Market

Hospital Infection Prevention And Control Market By Type of Product (Disinfectants and Sterilization Products, Personal Protective Equipment (PPE), Devices and Equipment, Monitoring and Surveillance Systems, Education and Training Services); By Infection Type (Surgical Site Infections (SSIs), Central Line-Associated Bloodstream Infections (CLABSIs), Ventilator-Associated Pneumonia (VAP), Catheter-Associated Urinary Tract Infections (CAUTIs), Clostridioides difficile Infections (CDIs), Multidrug-Resistant Organisms (MDROs)); By End-User (Hospitals and Clinics, Long-Term Care Facilities, Ambulatory Surgical Centers, Diagnostic Laboratories, Pharmaceutical Companies) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $4699

Published: | Report ID: 7217 | Report Format : Excel, PDF
REPORT ATTRIBUTE DETAILS
Historical Period 2019-2022
Base Year 2023
Forecast Period 2024-2032
Hospital Infection Prevention And Control Market Size 2023 USD 29541.50 Million
Hospital Infection Prevention And Control Market, CAGR 7.60%
Hospital Infection Prevention And Control Market Size 2032 USD 57114.05 Million

Market Insights

  • The global demand for hospital infection prevention and control products was valued at USD 29541.50 Million in 2023 and is expected to reach USD 57114.05 Million in 2032, growing at a CAGR of 7.60% between 2024 and 2032.
  • The disinfectants and sterilization Product segment is the market leader by type of product, accounting for a significant portion of total value in 2023, while the monitoring and surveillance systems segment is expected to grow rapidly throughout the forecast period.
  • The catheter-associated urinary tract infections (CAUTIs) segment dominates the market by infection type, accounting for a significant share in 2023. The multidrug-resistant organisms (MDROs) segment is predicted to expand at a high CAGR.
  • Over the projection period, long-term care facilities are expected to expand at the highest rate, while hospitals and clinics dominate the market by end-user with a substantial share in 2023.
  • North America is dominating the hospital infection prevention and control industry with a substantial share in 2023, while Asia Pacific is expected to grow at the highest rate during the forecast period.
  • The market’s primary possibilities include technological advancements in sterilization and disinfection, growing public awareness about hospital-acquired infections, and stricter regulations by healthcare authorities.

Executive Summary

Market Definition

Hospital Infection Prevention and Control (HIPC) is a comprehensive framework aimed at preventing and managing infections within healthcare facilities to protect patients, healthcare workers, and visitors. This involves continuous surveillance and monitoring of infection rates, promoting rigorous hand hygiene practices, and implementing standard and transmission-based precautions. Key strategies include proper sterilization and disinfection of medical equipment, antimicrobial stewardship to prevent resistant infections, and regular education and training for healthcare staff. Additionally, HIPC engages patients and visitors in infection prevention efforts, ensuring a collaborative approach to minimizing healthcare-associated infections and enhancing patient safety and outcomes.

Design Element 2

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

CTA Design Element 3

Market Overview

The global hospital infection prevention and control market has witnessed steady growth in recent years and is expected to grow at a CAGR of 7.60% between 2024 and 2032. The market was valued at USD 29541.50 million in 2023 and is expected to reach USD 57114.05 million in 2032.

The growth of the hospital infection prevention and control market is significantly driven by the increasing prevalence of healthcare-associated infections (HAIs) has heightened awareness and demand for effective infection control measures. HAIs pose significant risks to patient safety, leading to extended hospital stays, higher medical costs, and increased mortality rates, thus compelling healthcare facilities to invest in robust HIPC programs. Additionally, stringent government regulations and accreditation standards mandating infection control protocols have further propelled market expansion as compliance becomes essential for the operational legitimacy of healthcare institutions.

Technological advancements also play a pivotal role in driving the HIPC market. Innovations in sterilization and disinfection technologies, such as ultraviolet (UV) disinfection systems and automated cleaning robots, enhance the efficiency and effectiveness of infection control practices. These cutting-edge solutions offer improved outcomes and operational efficiencies, making them attractive investments for healthcare providers. Moreover, the rise of antimicrobial resistance has increased the need for comprehensive antimicrobial stewardship programs, spurring demand for advanced HIPC products and services to mitigate the spread of resistant pathogens.

Moreover, healthcare expenditures are increasing, particularly in emerging economies such as China and India. As these countries invest more in their healthcare infrastructure to improve the quality of care, there is a parallel increase in the adoption of HIPC measures. The expansion of healthcare facilities, coupled with the rising number of surgeries and invasive procedures, necessitates enhanced infection prevention protocols, further driving market demand. Furthermore, the ongoing COVID-19 pandemic has spotlighted the critical importance of infection control, leading to heightened investments in HIPC products and services globally.

Furthermore, growing patient awareness and expectations regarding healthcare safety and quality are influencing the market. Patients are increasingly informed about the risks of HAIs and demand higher standards of care, prompting healthcare providers to prioritize infection control measures. This shift in patient expectations, along with the competitive landscape of the healthcare sector, where institutions strive to build a reputation for safety and excellence, significantly boosts the HIPC market.

Segmentation by Type of Product

  • The disinfectants and sterilization product is the leading segment by type of product and holds a substantial share in 2023. This dominance is attributed to the critical role these products play in maintaining hygiene and preventing the spread of infections in hospital settings. The frequent need for disinfection and sterilization of surfaces, instruments, and medical devices drives the substantial demand for these products. Additionally, the ongoing emphasis on infection control and the rising incidence of healthcare-associated infections (HAIs) further bolster their market share.
  • Monitoring and Surveillance Systems is the fastest-growing segment due to the increasing focus on real-time infection tracking and prevention. With advancements in technology, hospitals are adopting sophisticated monitoring and surveillance systems to detect and manage infections more effectively. These systems help in early identification of infection outbreaks, ensuring timely intervention and reducing the spread of infections. The growing emphasis on improving patient outcomes and the need for efficient infection control measures are key factors driving the growth of this segment.
  • Other segments , such as personal protective equipment (PPE), devices and equipment, and education and training services, also contribute substantially to the market’s growth.

Segmentation by Infection Type

  • Catheter-associated urinary Tract Infections (CAUTIs) boast the dominating position in the Hospital Infection Prevention and Control industry, holding a massive share in 2023. CAUTIs are the most common type of healthcare-associated infections (HAIs), accounting for a significant portion of infections in hospitals. This high prevalence is due to the frequent use of urinary catheters in hospital settings, particularly among patients who require prolonged catheterization. The prevention and control of CAUTIs necessitate the use of various infection control products and protocols, driving substantial demand in this segment.
  • The Multidrug-resistant organisms (MDROs) are expected to grow with the highest CAGR during the projected period due to the increasing challenge posed by antibiotic-resistant infections. The rise of MDROs, such as MRSA (Methicillin-Resistant Staphylococcus Aureus) and VRE (Vancomycin-Resistant Enterococci), necessitates enhanced infection control measures. Hospitals are increasingly investing in advanced monitoring and surveillance systems, rigorous sterilization techniques, and comprehensive education and training programs for healthcare personnel to address these resistant infections.
  • Other infection types, including surgical site infections (SSIs), central line-associated bloodstream infections (CLABSIs), ventilator-associated pneumonia (VAP), and clostridioides difficile infections (CDIs), further contribute significantly to the growth of the market.

Segmentation by End-User

  • The Hospitals and Clinics boast the dominating position in the Hospital Infection Prevention and Control industry, holding a massive share in 2023. Hospitals and clinics are the primary settings for patient care and treatment, making infection prevention and control critical. The high volume of patients, frequent surgical procedures, and the need for sterile environments drive significant demand for infection prevention products and services. Additionally, regulatory requirements and accreditation standards necessitate stringent infection control practices in these settings, further contributing to their dominant market share.
  • Long-term care Facilities are expected to grow at the highest rate, driven by the aging population and the increasing prevalence of chronic diseases requiring long-term care. Due to the close living quarters and the often compromised health of residents, long-term care facilities, such as nursing homes and assisted living facilities, are particularly vulnerable to infections. This necessitates enhanced infection control measures, including regular disinfection, use of personal protective equipment (PPE), and staff training, leading to rapid growth in this market segment.
  • Other end-user segments, such as ambulatory surgical centers, diagnostic laboratories, and pharmaceutical companies, contribute significantly to the growth of the market.

Segmentation by Region

  • North America dominates the Hospital Infection Prevention and Control industry with a massive share in 2023 due to the region’s advanced healthcare systems and stringent infection control regulations. Additionally, chronic diseases, including cardiovascular diseases and cancer, contribute to increased hospital admissions, leading to market growth.
  • The Asia Pacific market is expected to grow at the highest rate during the forecasted period.
  • The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for the Hospital Infection Prevention and Control industry.

North America holds a significant share in the Hospital Infection Prevention and Control industry due to its advanced healthcare systems, stringent infection control regulations, and the development of innovative infection control technologies. The Centers for Disease Control (CDC) estimates that healthcare-associated infections (HAIs) cause 1.7 million infections and 99,000 deaths annually in American hospitals alone, emphasizing the need for effective infection control measures to drive market growth.

Additionally, the increasing prevalence of chronic diseases, including cardiovascular diseases and cancer, contributes to increased hospital admissions, which leads to market growth. According to 2022 data from the American Health Association, there were approximately 33 million hospital admissions in the U.S., highlighting the substantial demand for infection control solutions. The increased number of hospital admissions and longer patient stays elevate the risk of hospital infections, further driving the need for advanced treatment options.

Moreover, innovative technological advancements play a pivotal role in bolstering market expansion. For instance, Penn Medicine’s recent establishment of the Interventional Support Center (ISC) in Southwest Philadelphia exemplifies this trend. The ISC, one of Pennsylvania’s largest instrument processing facilities, uses cutting-edge sterilization processes to enhance infection control practices, driving market growth by setting new standards for infection prevention in the region.

On the other hand, the Asia-Pacific region offers significant growth opportunities in the hospital infection prevention and control market, driven by demographic shifts and healthcare infrastructure investments. With the Asia-Pacific population aging faster than any other region, the prevalence of hospital-related infections is expected to surge. This demographic shift results in a higher susceptibility to infections among the elderly, necessitating specialized treatment and prevention measures.

In addition, governments across the Asia-Pacific region are making substantial investments in healthcare infrastructure to address evolving healthcare needs. Initiatives such as India’s establishment of infectious disease (ID) blocks and the National Action Plan (NAP) to combat antimicrobial resistance (AMR) demonstrate efforts to enhance healthcare facilities and services, driving market growth in the region.

Furthermore, international collaborations play a vital role in addressing hospital infections in the Asia-Pacific region. Partnerships between local healthcare authorities and international organizations bring technical expertise and financial support to strengthen infection Prevention and Control measures. Collaborations between the Indian Council of Medical Research (ICMR), All India Institute of Medical Sciences (AIIMS), and the Centers for Disease Control and Prevention (CDC) of the USA are crucial in intensive care units (ICUs), where the risk of hospital-related infections is high. The involvement of global health entities such as the World Health Organization (WHO) underscores the importance of addressing hospital infections in low- and middle-income countries, highlighting the market growth prospects in the Asia-Pacific region.

Hospital Infection Prevention And Control Market

Key Highlights of the Report

The global Hospital Infection Prevention and Control Market is segmented by type of product, infection type, end-user, and region.  Disinfectants and Sterilization Products are the most popular segment, while Catheter-Associated Urinary Tract Infections (CAUTIs) are the primary infection type. In addition, Hospitals and Clinics are the most demanding end-users, with the North American region leading the market share.

The growth of the Hospital Infection Prevention and Control industry is due to the rising prevalence of healthcare-associated infections (HAIs) that lead to extended hospital stays, increased costs, and higher mortality rates. Government regulations and accreditation standards mandating infection control protocols further propel market growth. Moreover, increasing healthcare expenditure, especially in emerging economies, along with the expansion of healthcare facilities and the rise in surgeries, necessitate enhanced infection prevention protocols.

Nonetheless, North America is anticipated to have the largest share of the worldwide Hospital Infection Prevention and Control Market due to the region’s advanced healthcare systems and stringent infection control regulations. Additionally, the rising prevalence of chronic diseases, including cardiovascular diseases and cancer, contributes to increased hospital admissions. Furthermore, the market is anticipated to expand at the highest rate in the Asia-Pacific region due to the region’s demographic shifts and increased healthcare infrastructure investments to address evolving healthcare needs.

What Are the Main Drivers of the Global Hospital Infection Prevention and Control Market?

The growth of the Hospital Infection Prevention and Control (HIPC) market is driven by the increasing prevalence of healthcare-associated infections (HAIs), which result in prolonged hospital stays, higher costs, and elevated mortality rates. Additionally, government regulations and accreditation standards mandating infection control protocols significantly boost market expansion. Furthermore, rising healthcare expenditure, particularly in emerging economies, coupled with the expansion of healthcare facilities and an increase in surgeries, necessitates the implementation of enhanced infection prevention protocols.

What Are the Major Challenges Faced by the Global Hospital Infection Prevention and Control Market?

The high cost associated with advanced hospital infection Prevention and Control technologies poses a significant challenge for the market growth. These costs can pose significant barriers, particularly for smaller healthcare facilities and institutions in developing regions with limited financial resources. Consequently, the adoption of comprehensive HIPC measures is often restricted in these settings, impeding the broader implementation of effective infection prevention strategies.

What Are the Growth Opportunities in the Global Hospital Infection Prevention and Control Market?

Technological advancements represent a significant opportunity for innovation and growth in the HIPC market in the future. Technological advancements, including smart disinfection systems, antimicrobial surfaces, and real-time monitoring tools, are revolutionizing infection control in healthcare. These innovations enhance HIPC strategies by offering targeted disinfection, microbial inhibition, and continuous surveillance.

Market Drivers

Growing Incidence of Various Types of Hospital-Acquired Infections (HAIs)

The growth of the Hospital Infection Prevention and Control industry is significantly driven by the rising incidence of various types of hospital-acquired infections (HAIs). According to the Centers for Disease Control and Prevention (CDC), catheter-associated urinary tract infections (CAUTIs) are among the most common types of healthcare-associated infections. Approximately 75% of urinary tract infections (UTIs) developed in hospitals are linked to the use of urinary catheters, with 15-25% of hospitalized patients requiring these devices. CAUTIs contribute to increased morbidity, mortality, healthcare costs, and extended hospital stays, underscoring the need for effective treatment and prevention strategies.

Additionally, a 2022 report from the World Health Organization (WHO) highlights the global burden of HAIs. It reveals that out of every 100 patients in acute-care hospitals, seven patients in high-income countries and 15 patients in low- and middle-income countries acquire at least one healthcare-associated infection during their hospital stay. Alarmingly, on average, one in every ten affected patients will die from their HAI. The impact of HAIs and antimicrobial resistance on patient outcomes is profound, with over 24% of patients affected by healthcare-associated sepsis and 52.3% of those treated in intensive care units succumbing to these infections annually. The mortality rate increases two to threefold when infections are resistant to antimicrobials, emphasizing the urgent need for advanced treatment options and robust infection control measures.

The increasing recognition of these infections’ impact on patient health, hospital resources, and healthcare costs is spurring investments in the development and deployment of innovative diagnostic and therapeutic solutions. Enhanced infection control protocols and regulatory frameworks further support this growth as healthcare systems worldwide strive to mitigate the risks and outcomes associated with HAIs.

Market Restraints

High Cost Associated with Hospital Infection Prevention and Control

The growth of the Hospital Infection Prevention and Control (HIPC) market is significantly restrained by the high costs associated with advanced infection control technologies and products. These expenses can be particularly prohibitive for smaller healthcare facilities and those in developing regions, where financial resources are limited. Consequently, the adoption of comprehensive HIPC measures is often hindered in such resource-constrained settings. Moreover, the lack of awareness and education about the importance of infection control practices among healthcare workers and administrators in certain regions further exacerbates this challenge. Without a clear understanding of the critical role played by rigorous infection control measures, there is insufficient investment in training and resources. This, in turn, results in suboptimal implementation of HIPC measures, compromising their effectiveness and overall impact on patient safety and healthcare outcomes.

Opportunities

Advancements in Medical Technologies

Technological advancements are poised to create substantial opportunities for the hospital infection prevention and control market in the future. Innovations such as smart disinfection systems, antimicrobial surfaces, and real-time monitoring tools are transforming the landscape of infection Prevention and Control. These breakthrough technologies offer advanced capabilities that significantly enhance the effectiveness and efficiency of HIPC strategies.

Smart disinfection systems employ automation and intelligent sensors to deliver targeted and comprehensive disinfection of healthcare environments, thereby reducing the risk of pathogen transmission. Also, the antimicrobial surfaces integrate materials engineered to inhibit the growth and spread of microorganisms, providing an additional layer of protection against infectious agents. Meanwhile, real-time monitoring tools enable continuous surveillance of critical parameters such as air quality, surface cleanliness, and hand hygiene compliance, empowering healthcare facilities to identify and address infection risks proactively. These innovative tools not only enhance patient safety by curbing the incidence of healthcare-associated infections (HAIs) but also yield operational efficiencies and cost savings for healthcare facilities. By harnessing these technological advancements, healthcare providers can fortify their infection prevention strategies, enhance patient outcomes, and ensure the safety of both patients and healthcare workers.

Competitive Landscape

Key Players

The global hospital infection prevention and control market is highly competitive, with several key players. Some of the major players in the market are as follows:

  • Pfizer Inc.
  • Hoffmann-La Roche Ltd (Roche)
  • Merck & Co., Inc.
  • Johnson & Johnson
  • Abbott Laboratories (Abbott)
  • Bayer AG
  • Becton, Dickinson and Company (BD)
  • Kimberly-Clark Corporation
  • Nordion
  • Cepheid

These organizations prioritize product innovation to stay competitive.

The key players in the global hospital infection prevention and control market continually seek to stay ahead by innovating new products.

In March 2024, Pfizer received marketing authorization from the European Medicines Agency (EMA) for its novel antibiotic combination, EMBLAVEO (aztreonam-avibactam). This combination is designed to combat infections caused by Gram-negative bacteria, including those resistant to nearly all available antibiotics. The treatment is indicated for complicated intra-abdominal infections, hospital-acquired pneumonia, ventilator-associated pneumonia, and complicated urinary tract infections.

How are Companies Performing in the Hospital Infection Prevention and Control Market?

The global hospital infection prevention and control market is highly competitive, with several key players.

Startups are playing a pivotal role in driving innovation and shaping the future of the Hospital Infection Prevention and Control industry. Startups are aiming to combat the increasing incidence of hospital-acquired infections (HAIs) and multidrug-resistant (MDR) pathogens. These infections pose a substantial challenge to healthcare systems worldwide, and startups are leveraging advanced technologies to offer effective solutions.

Adsense, a British startup, addresses the critical need for accurate and early diagnosis of hospital-acquired infections through a portable electronic biosensor. The biosensor rapidly detects infections caused by pathogens such as Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumonia, Staphylococcus aureus, and Enterococcus spp. By measuring the host response using proteomic and electrochemical sensing technology, Aksense’s point-of-care device significantly reduces diagnosis timelines from days to minutes, enabling timely and appropriate treatment to prevent HAIs.

Similarly, the integration of robotic technology in healthcare is revolutionizing the medical sector, particularly in the area of disinfection. Canadian startup Solaris has developed the Lytbot, a mobile robot that uses germicidal UV-C light and pulsed UV technologies to disinfect large surfaces. The 254 nm germicidal UV-C light disrupts pathogen cells, preventing them from functioning and replicating. The Lytbot complements traditional disinfection methods by eliminating a wide range of harmful bacteria and pathogens, thereby enhancing the overall hygiene of healthcare environments.

Summary of Key Findings

  • The growth of the Hospital Infection Prevention and Control (HIPC) industry is driven by the increasing prevalence of healthcare-associated infections (HAIs), which result in prolonged hospital stays, higher costs, and elevated mortality rates. Additionally, government regulations and accreditation standards mandating infection control protocols significantly boost market expansion. Furthermore, rising healthcare expenditure, particularly in emerging economies, coupled with the expansion of healthcare facilities and an increase in surgeries, necessitates the implementation of enhanced infection prevention protocols.
  • Market segmented by type of product, infection type, end-user, and region.
  • Disinfectants and sterilization products are the leading segment by type of product and hold a substantial share as they effectively eliminate a broad spectrum of pathogens, ensuring a safer hospital environment.
  • Catheter-associated urinary Tract Infections (CAUTIs) boast the dominating position in the Hospital Infection Prevention and Control industry, holding a massive share in 2023 as they are the most common type of hospital-acquired infection, necessitating extensive prevention and control measures.
  • North America is leading market growth; the market is highly competitive with key players including Pfizer Inc., F. Hoffmann-La Roche Ltd (Roche), Merck & Co., Inc., Johnson & Johnson, Abbott, Bayer AG, Becton, Dickinson and Company (BD), Kimberly-Clark Corporation, Nordion, Cepheid, and Others.

Future Outlook

  • Positive outlook for the global hospital infection prevention and control market with significant growth potential in the Asia Pacific region.
  • One of the main factors promoting the market’s expansion is the increasing prevalence of healthcare-associated infections (HAIs), along with government regulations and accreditation standards mandating infection control protocols.
  • During the forecast period, high cost associated with advanced hospital infection Prevention and Control technologies is expected to act as significant factors restraining the growth of the Hospital Infection Prevention and Control Market.
  • To stay competitive, key firms in the hospital infection prevention and control market should prioritize innovation in sterilization technologies, implementation of stringent hygiene protocols, development of advanced antimicrobial products, and continuous investment in research and development for effective infection control solutions.

How CXOs Can Benefit from the Credence Research Hospital Infection Prevention and Control Market Report

The Credence Research Hospital Infection Prevention and Control Market Report provides CXOs with a comprehensive overview of the market, including:

  • Market size and growth forecast: The report provides detailed estimates of the global hospital infection prevention and control market size, segmented by type of product, infection type, end-user, and region. It also includes forecasts for the market through 2032 based on key trends and drivers.
  • Market segmentation: The report segments the hospital infection prevention and control market by type of product, infection type, end-user, and region. This segmentation provides CXOs with a granular understanding of the market and the opportunities in each segment.
  • Competitive Landscape: The report profiles the key players in the hospital infection prevention and control market and provides insights into their strategies, product offerings, and financial performance. This information can help CXOs to identify and assess their competition.
  • Key trends and drivers: The report identifies and analyses the key trends and drivers shaping the hospital infection prevention and control market. This information can help CXOs make informed decisions about their investments and strategies.

CXOs can use the insights from the Credence Research Hospital Infection Prevention and Control Market Report to:

  • Identify growth opportunities: The report can help CXOs to identify new growth opportunities in the Hospital Infection Prevention and Control Market. For example, the report identifies the growing prevalence of healthcare-associated infections (HAIs) and rising healthcare expenditure, particularly in emerging economies.
  • Make informed investment decisions: The report can help CXOs make informed investment decisions about the hospital infection prevention and control industry. For example, it provides insights into the key factors to consider when evaluating and selecting Hospital Infection Prevention and Control providers.
  • Develop competitive strategies: The report can help CXOs develop competitive strategies for their hospital infection prevention and control businesses. For example, it identifies the key strategies that hospital infection prevention and control product providers are using to differentiate themselves from their competitors.
  • Track market developments: The report can help CXOs monitor market developments and stay ahead of the curve. For example, it provides insights into the latest trends and innovations in the hospital infection prevention and control market.

Overall, the Credence Research Hospital Infection Prevention and Control Market Report is a valuable resource for CXOs who are looking to gain a deeper understanding of the market and identify opportunities for growth.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Segmentation

  • By Type of Product

    • Disinfectants and Sterilization Products
    • Personal Protective Equipment (PPE)
    • Devices and Equipment
    • Monitoring and Surveillance Systems
    • Education and Training Services

  • By Infection Type

    • Surgical Site Infections (SSIs)
    • Central Line-Associated Bloodstream Infections (CLABSIs)
    • Ventilator-Associated Pneumonia (VAP)
    • Catheter-Associated Urinary Tract Infections (CAUTIs)
    • Clostridioides difficile Infections (CDIs)
    • Multidrug-Resistant Organisms (MDROs)

  • By End-User

    • Hospitals and Clinics
    • Long-Term Care Facilities
    • Ambulatory Surgical Centers
    • Diagnostic Laboratories
    • Pharmaceutical Companies

  • By Region

    • North Americas
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of the Middle East and Africa

Adjacent Markets

In the Hospital Infection Prevention and Control Market, several adjacent markets have high revenue growth opportunities. The key adjacent markets for Hospital Infection Prevention and Control Market –

                                                        Adjacent Markets
Medical Device Sterilization Market Antimicrobial Coatings Market Brain Aneurysm Treatment Devices Market
Disinfectants and Sanitizers Market Diagnostic Testing for Infectious Diseases Market Devices Market Surgical Instruments Market
Healthcare Facility Management Services Market Biotechnology Research and Development Market Healthcare-associated Infection (HAI) Testing Market

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction

2. Executive Summary
2.1. Market Snapshot: Global Hospital Infection Prevention and Control Market
2.1.1. Global Hospital Infection Prevention and Control Market, By Type of Product
2.1.2. Global Hospital Infection Prevention and Control Market, By Infection Type
2.1.3. Global Hospital Infection Prevention and Control Market, By End-User
2.1.4. Global Hospital Infection Prevention and Control Market, By Region
2.2. Insights from Primary Respondents

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Hospital Infection Prevention and Control Market Value, 2019-2032, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Hospital Infection Prevention and Control Market Drivers
3.2.2. Hospital Infection Prevention and Control Market Restraints
3.2.3. Hospital Infection Prevention and Control Market Opportunities
3.2.4. Major Hospital Infection Prevention and Control Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type of Product
3.5.2. Infection Type
3.5.3. End-User
3.5.4. Geography

4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2023
4.1.1. Global Hospital Infection Prevention and Control Market: Company Market Share, Value 2023
4.1.2. Global Hospital Infection Prevention and Control Market: Top 6 Company Market Share, Value 2023
4.1.3. Global Hospital Infection Prevention and Control Market: Top 3 Company Market Share, Value 2023
4.2. Global Hospital Infection Prevention and Control Market: Company Revenue Share Analysis, 2023
4.3. Company Assessment Metrics, 2023
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2023
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the Global Hospital Infection Prevention and Control Market

5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research and development in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis

6. Market Positioning of Key Players, 2023
6.1. Company market share of key players, 2023
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others

7. Impact Analysis of COVID 19 and Russia – Ukraine War on Hospital Infection Prevention and Control Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa

8. Global Hospital Infection Prevention and Control Market, By Type of Product
8.1. Global Hospital Infection Prevention and Control Market Overview, by Type of Product
8.1.1. Global Hospital Infection Prevention and Control Market Revenue Share, By Type of Product, 2023 Vs 2032 (in %)
8.2. Disinfectants and Sterilization Products
8.2.1. Global Hospital Infection Prevention and Control Market, By Disinfectants and Sterilization Products, By Region, 2019-2032 (US$ Mn)
8.2.2. Market Dynamics for Disinfectants and Sterilization Products
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Personal Protective Equipment (PPE)
8.3.1. Global Hospital Infection Prevention and Control Market, By Personal Protective Equipment (PPE), By Region, 2019-2032 (US$ Mn)
8.3.2. Market Dynamics for Personal Protective Equipment (PPE)
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
8.4. Devices and Equipment
8.4.1. Global Hospital Infection Prevention and Control Market, By Devices and Equipment, By Region, 2019-2032 (US$ Mn)
8.4.2. Market Dynamics for Devices and Equipment
8.4.2.1. Drivers
8.4.2.2. Restraints
8.4.2.3. Opportunities
8.4.2.4. Trends
8.5. Monitoring and Surveillance Systems
8.5.1. Global Hospital Infection Prevention and Control Market, By Monitoring and Surveillance Systems, By Region, 2019-2032 (US$ Mn)
8.5.2. Market Dynamics for Monitoring and Surveillance Systems
8.5.2.1. Drivers
8.5.2.2. Restraints
8.5.2.3. Opportunities
8.5.2.4. Trends
8.6. Education and Training Services
8.6.1. Global Hospital Infection Prevention and Control Market, By Education and Training Services, By Region, 2019-2032 (US$ Mn)
8.6.2. Market Dynamics for Education and Training Services
8.6.2.1. Drivers
8.6.2.2. Restraints
8.6.2.3. Opportunities
8.6.2.4. Trends

9. Global Hospital Infection Prevention and Control Market, By Infection Type
9.1. Global Hospital Infection Prevention and Control Market Overview, by Infection Type
9.1.1. Global Hospital Infection Prevention and Control Market Revenue Share, By Infection Type, 2023 Vs 2032 (in %)
9.2. Surgical Site Infections (SSIs)
9.2.1. Global Hospital Infection Prevention and Control Market, By Surgical Site Infections (SSIs), By Region, 2019-2032 (US$ Mn)
9.2.2. Market Dynamics for Surgical Site Infections (SSIs)
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Central Line-Associated Bloodstream Infections (CLABSIs)
9.3.1. Global Hospital Infection Prevention and Control Market, By Central Line-Associated Bloodstream Infections (CLABSIs), By Region, 2019-2032 (US$ Mn)
9.3.2. Market Dynamics for Central Line-Associated Bloodstream Infections (CLABSIs)
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Ventilator-Associated Pneumonia (VAP)
9.4.1. Global Hospital Infection Prevention and Control Market, By Ventilator-Associated Pneumonia (VAP), By Region, 2019-2032 (US$ Mn)
9.4.2. Market Dynamics for Ventilator-Associated Pneumonia (VAP)
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends
9.5. Catheter-Associated Urinary Tract Infections (CAUTIs)
9.5.1. Global Hospital Infection Prevention and Control Market, By Catheter-Associated Urinary Tract Infections (CAUTIs), By Region, 2019-2032 (US$ Mn)
9.5.2. Market Dynamics for Catheter-Associated Urinary Tract Infections (CAUTIs)
9.5.2.1. Drivers
9.5.2.2. Restraints
9.5.2.3. Opportunities
9.5.2.4. Trends
9.6. Clostridioides difficile Infections (CDIs)
9.6.1. Global Hospital Infection Prevention and Control Market, By Clostridioides difficile Infections (CDIs), By Region, 2019-2032 (US$ Mn)
9.6.2. Market Dynamics for Clostridioides difficile Infections (CDIs)
9.6.2.1. Drivers
9.6.2.2. Restraints
9.6.2.3. Opportunities
9.6.2.4. Trends
9.7. Multidrug-Resistant Organisms (MDROs)
9.7.1. Global Hospital Infection Prevention and Control Market, By Multidrug-Resistant Organisms (MDROs), By Region, 2019-2032 (US$ Mn)
9.7.2. Market Dynamics for Multidrug-Resistant Organisms (MDROs)
9.7.2.1. Drivers
9.7.2.2. Restraints
9.7.2.3. Opportunities
9.7.2.4. Trends

10. Global Hospital Infection Prevention and Control Market, By End-User
10.1. Global Hospital Infection Prevention and Control Market Overview, by End-User
10.1.1. Global Hospital Infection Prevention and Control Market Revenue Share, By End-User, 2023 Vs 2032 (in %)
10.2. Hospitals and Clinics
10.2.1. Global Hospital Infection Prevention and Control Market, By Hospitals and Clinics, By Region, 2019-2032 (US$ Mn)
10.2.2. Market Dynamics for Hospitals and Clinics
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Long-Term Care Facilities
10.3.1. Global Hospital Infection Prevention and Control Market, By Long-Term Care Facilities, By Region, 2019-2032 (US$ Mn)
10.3.2. Market Dynamics for Long-Term Care Facilities
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
10.4. Ambulatory Surgical Centers
10.4.1. Global Hospital Infection Prevention and Control Market, By Ambulatory Surgical Centers, By Region, 2019-2032 (US$ Mn)
10.4.2. Market Dynamics for Ambulatory Surgical Centers
10.4.2.1. Drivers
10.4.2.2. Restraints
10.4.2.3. Opportunities
10.4.2.4. Trends
10.5. Diagnostic Laboratories
10.5.1. Global Hospital Infection Prevention and Control Market, By Diagnostic Laboratories, By Region, 2019-2032 (US$ Mn)
10.5.2. Market Dynamics for Diagnostic Laboratories
10.5.2.1. Drivers
10.5.2.2. Restraints
10.5.2.3. Opportunities
10.5.2.4. Trends
10.6. Pharmaceutical Companies
10.6.1. Global Hospital Infection Prevention and Control Market, By Pharmaceutical Companies, By Region, 2019-2032 (US$ Mn)
10.6.2. Market Dynamics for Pharmaceutical Companies
10.6.2.1. Drivers
10.6.2.2. Restraints
10.6.2.3. Opportunities
10.6.2.4. Trends

11. Global Hospital Infection Prevention and Control Market, By Region
11.1. Global Hospital Infection Prevention and Control Market Overview, by Region
11.1.1. Global Hospital Infection Prevention and Control Market, By Region, 2023 vs 2032 (in%)
11.2. Type of Product
11.2.1. Global Hospital Infection Prevention and Control Market, By Type of Product, 2019-2032 (US$ Mn)
11.3. Infection Type
11.3.1. Global Hospital Infection Prevention and Control Market, By Infection Type, 2019-2032 (US$ Mn)
11.4. End-User
11.4.1. Global Hospital Infection Prevention and Control Market, By End-User, 2019-2032 (US$ Mn)

12. North America Hospital Infection Prevention and Control Market Analysis
12.1. Overview
12.1.1. Market Dynamics for North America
12.1.1.1. Drivers
12.1.1.2. Restraints
12.1.1.3. Opportunities
12.1.1.4. Trends
12.2. North America Hospital Infection Prevention and Control Market, by Type of Product, 2019-2032(US$ Mn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. North America Hospital Infection Prevention and Control Market, by Infection Type, 2019-2032(US$ Mn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. North America Hospital Infection Prevention and Control Market, by End-User, 2019-2032(US$ Mn)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. North America Hospital Infection Prevention and Control Market, by Country, 2019-2032 (US$ Mn)
12.5.1. North America Hospital Infection Prevention and Control Market, by Country, 2023 Vs 2032 (in%)
12.5.2. U.S.
12.5.3. Canada
12.5.4. Mexico

13. Europe Hospital Infection Prevention and Control Market Analysis
13.1. Overview
13.1.1. Market Dynamics for Europe
13.1.1.1. Drivers
13.1.1.2. Restraints
13.1.1.3. Opportunities
13.1.1.4. Trends
13.2. Europe Hospital Infection Prevention and Control Market, by Type of Product, 2019-2032(US$ Mn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Europe Hospital Infection Prevention and Control Market, by Infection Type, 2019-2032(US$ Mn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Europe Hospital Infection Prevention and Control Market, by End-User, 2019-2032(US$ Mn)
13.4.1. Overview
13.4.2. SRC Analysis
13.5. Europe Hospital Infection Prevention and Control Market, by Country, 2019-2032 (US$ Mn)
13.5.1. Europe Hospital Infection Prevention and Control Market, by Country, 2023 Vs 2032 (in%)
13.5.2. Germany
13.5.3. French
13.5.4. UK
13.5.5. Italy
13.5.6. Spain
13.5.7. Benelux
13.5.8. Russia
13.5.9. Rest of Europe

14. Asia Pacific Hospital Infection Prevention and Control Market Analysis
14.1. Overview
14.1.1. Market Dynamics for Asia Pacific
14.1.1.1. Drivers
14.1.1.2. Restraints
14.1.1.3. Opportunities
14.1.1.4. Trends
14.2. Asia Pacific Hospital Infection Prevention and Control Market, by Type of Product, 2019-2032(US$ Mn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Asia Pacific Hospital Infection Prevention and Control Market, by Infection Type, 2019-2032(US$ Mn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Asia Pacific Hospital Infection Prevention and Control Market, by End-User, 2019-2032(US$ Mn)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. Asia Pacific Hospital Infection Prevention and Control Market, by Country, 2019-2032 (US$ Mn)
14.5.1. Asia Pacific Hospital Infection Prevention and Control Market, by Country, 2023 Vs 2032 (in%)
14.5.2. China
14.5.3. Japan
14.5.4. India
14.5.5. South Korea
14.5.6. South East Asia
14.5.7. Rest of Asia Pacific

15. Latin America Hospital Infection Prevention and Control Market Analysis

15.1. Overview
15.1.1. Market Dynamics for Latin America
15.1.1.1. Drivers
15.1.1.2. Restraints
15.1.1.3. Opportunities
15.1.1.4. Trends
15.2. Latin America Hospital Infection Prevention and Control Market, by Type of Product, 2019-2032(US$ Mn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Latin America Hospital Infection Prevention and Control Market, by Infection Type, 2019-2032(US$ Mn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Latin America Hospital Infection Prevention and Control Market, by End-User, 2019-2032(US$ Mn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Latin America Hospital Infection Prevention and Control Market, by Country, 2019-2032 (US$ Mn)
15.5.1. Latin America Hospital Infection Prevention and Control Market, by Country, 2023 Vs 2032 (in%)
15.5.2. Brazil
15.5.3. Argentina
15.5.4. Rest of Latin America

16. Middle East Hospital Infection Prevention and Control Market Analysis
16.1. Overview
16.1.1. Market Dynamics for Middle East
16.1.1.1. Drivers
16.1.1.2. Restraints
16.1.1.3. Opportunities
16.1.1.4. Trends
16.2. Middle East Hospital Infection Prevention and Control Market, by Type of Product, 2019-2032(US$ Mn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Middle East Hospital Infection Prevention and Control Market, by Infection Type, 2019-2032(US$ Mn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Middle East Hospital Infection Prevention and Control Market, by End-User, 2019-2032(US$ Mn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Middle East Hospital Infection Prevention and Control Market, by Country, 2019-2032 (US$ Mn)
16.5.1. Middle East Hospital Infection Prevention and Control Market, by Country, 2023 Vs 2032 (in%)
16.5.2. UAE
16.5.3. Saudi Arabia
16.5.4. Rest of Middle East

17. Africa Hospital Infection Prevention and Control Market Analysis
17.1. Overview
17.1.1. Market Dynamics for Africa
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. Africa Hospital Infection Prevention and Control Market, by Type of Product, 2019-2032(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Africa Hospital Infection Prevention and Control Market, by Infection Type, 2019-2032(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Africa Hospital Infection Prevention and Control Market, by End-User, 2019-2032(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Africa Hospital Infection Prevention and Control Market, by Country, 2019-2032 (US$ Mn)
17.5.1. Middle East Hospital Infection Prevention and Control Market, by Country, 2023 Vs 2032 (in%)
17.5.2. South Africa
17.5.3. Egypt
17.5.4. Rest of Africa

18. Company Profiles
18.1. Pfizer Inc.
18.1.1. Company Overview
18.1.2. Products/Services Portfolio
18.1.3. Geographical Presence
18.1.4. SWOT Analysis
18.1.5. Financial Summary
18.1.5.1. Market Revenue and Net Profit (2019-2023)
18.1.5.2. Business Segment Revenue Analysis
18.1.5.3. Geographical Revenue Analysis
18.2. F. Hoffmann-La Roche Ltd (Roche)
18.3. Merck & Co., Inc.
18.4. Johnson & Johnson
18.5. Abbott
18.6. Bayer AG
18.7. Becton, Dickinson and Company (BD)
18.8. Kimberly-Clark Corporation
18.9. Nordion
18.10. Cepheid

19. Research Methodology
19.1. Research Methodology
19.2. Phase I – Secondary Research
19.3. Phase II – Data Modelling
19.3.1. Company Share Analysis Model
19.3.2. Revenue Based Modelling
19.4. Phase III – Primary Research
19.5. Research Limitations
19.5.1. Assumptions

List of Figures
FIG. 1 Global Hospital Infection Prevention and Control Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Hospital Infection Prevention and Control Market Segmentation
FIG. 4 Global Hospital Infection Prevention and Control Market, by Type of Product, 2023 (US$ Mn)
FIG. 5 Global Hospital Infection Prevention and Control Market, by Infection Type, 2023 (US$ Mn)
FIG. 6 Global Hospital Infection Prevention and Control Market, by End-User, 2023 (US$ Mn)
FIG. 7 Global Hospital Infection Prevention and Control Market, by Geography, 2023 (US$ Mn)
FIG. 8 Attractive Investment Proposition, by Type of Product, 2023
FIG. 9 Attractive Investment Proposition, by Infection Type, 2023
FIG. 10 Attractive Investment Proposition, by End-User, 2023
FIG. 11 Attractive Investment Proposition, by Geography, 2023
FIG. 12 Global Market Share Analysis of Key Hospital Infection Prevention and Control Market Manufacturers, 2023
FIG. 13 Global Market Positioning of Key Hospital Infection Prevention and Control Market Manufacturers, 2023
FIG. 14 Global Hospital Infection Prevention and Control Market Value Contribution, By Type of Product, 2023 & 2032 (Value %)
FIG. 15 Global Hospital Infection Prevention and Control Market, by Disinfectants and Sterilization Products, Value, 2019-2032 (US$ Mn)
FIG. 16 Global Hospital Infection Prevention and Control Market, by Personal Protective Equipment (PPE), Value, 2019-2032 (US$ Mn)
FIG. 17 Global Hospital Infection Prevention and Control Market, by Devices and Equipment, Value, 2019-2032 (US$ Mn)
FIG. 18 Global Hospital Infection Prevention and Control Market, by Monitoring and Surveillance Systems, Value, 2019-2032 (US$ Mn)
FIG. 19 Global Hospital Infection Prevention and Control Market, by Education and Training Services, Value, 2019-2032 (US$ Mn)
FIG. 20 Global Hospital Infection Prevention and Control Market Value Contribution, By Infection Type, 2023 & 2032 (Value %)
FIG. 21 Global Hospital Infection Prevention and Control Market, by Surgical Site Infections (SSIs), Value, 2019-2032 (US$ Mn)
FIG. 22 Global Hospital Infection Prevention and Control Market, by Central Line-Associated Bloodstream Infections (CLABSIs), Value, 2019-2032 (US$ Mn)
FIG. 23 Global Hospital Infection Prevention and Control Market, by Ventilator-Associated Pneumonia (VAP), Value, 2019-2032 (US$ Mn)
FIG. 24 Global Hospital Infection Prevention and Control Market, by Catheter-Associated Urinary Tract Infections (CAUTIs), Value, 2019-2032 (US$ Mn)
FIG. 25 Global Hospital Infection Prevention and Control Market, by Clostridioides difficile Infections (CDIs), Value, 2019-2032 (US$ Mn)
FIG. 26 Global Hospital Infection Prevention and Control Market, by Multidrug-Resistant Organisms (MDROs), Value, 2019-2032 (US$ Mn)
FIG. 27 Global Hospital Infection Prevention and Control Market Value Contribution, By End-User, 2023 & 2032 (Value %)
FIG. 28 Global Hospital Infection Prevention and Control Market, by Hospitals and Clinics, Value, 2019-2032 (US$ Mn)
FIG. 29 Global Hospital Infection Prevention and Control Market, by Long-Term Care Facilities, Value, 2019-2032 (US$ Mn)
FIG. 30 Global Hospital Infection Prevention and Control Market, by Ambulatory Surgical Centers, Value, 2019-2032 (US$ Mn)
FIG. 31 Global Hospital Infection Prevention and Control Market, by Diagnostic Laboratories, Value, 2019-2032 (US$ Mn)
FIG. 32 Global Hospital Infection Prevention and Control Market, by Pharmaceutical Companies, Value, 2019-2032 (US$ Mn)
FIG. 33 North America Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 34 U.S. Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 35 Canada Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 36 Mexico Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 37 Europe Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 38 Germany Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 39 France Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 40 U.K. Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 41 Italy Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 42 Spain Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 43 Benelux Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 44 Russia Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 45 Rest of Europe Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 46 Asia Pacific Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 47 China Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 48 Japan Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 49 India Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 50 South Korea Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 51 South-East Asia Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 52 Rest of Asia Pacific Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 53 Latin America Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 54 Brazil Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 55 Argentina Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 56 Rest of Latin America Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 57 Middle East Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 58 UAE Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 59 Saudi Arabia Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 60 Rest of Middle East Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 61 Africa Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 62 South Africa Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 63 Egypt Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)
FIG. 64 Rest of Africa Hospital Infection Prevention and Control Market, 2019-2032 (US$ Mn)

 

List of Tables
TABLE 1 Market Snapshot: Global Hospital Infection Prevention and Control Market
TABLE 2 Global Hospital Infection Prevention and Control Market: Market Drivers Impact Analysis
TABLE 3 Global Hospital Infection Prevention and Control Market: Market Restraints Impact Analysis
TABLE 4 Global Hospital Infection Prevention and Control Market, by Competitive Benchmarking, 2023
TABLE 5 Global Hospital Infection Prevention and Control Market, by Geographical Presence Analysis, 2023
TABLE 6 Global Hospital Infection Prevention and Control Market, by Key Strategies Analysis, 2023
TABLE 7 Global Hospital Infection Prevention and Control Market, by Disinfectants and Sterilization Products, By Region, 2019-2023 (US$ Mn)
TABLE 8 Global Hospital Infection Prevention and Control Market, by Disinfectants and Sterilization Products, By Region, 2024-2032 (US$ Mn)
TABLE 9 Global Hospital Infection Prevention and Control Market, by Personal Protective Equipment (PPE), By Region, 2019-2023 (US$ Mn)
TABLE 10 Global Hospital Infection Prevention and Control Market, by Personal Protective Equipment (PPE), By Region, 2024-2032 (US$ Mn)
TABLE 11 Global Hospital Infection Prevention and Control Market, by Devices and Equipment, By Region, 2019-2023 (US$ Mn)
TABLE 12 Global Hospital Infection Prevention and Control Market, by Devices and Equipment, By Region, 2024-2032 (US$ Mn)
TABLE 13 Global Hospital Infection Prevention and Control Market, by Monitoring and Surveillance Systems, By Region, 2019-2023 (US$ Mn)
TABLE 14 Global Hospital Infection Prevention and Control Market, by Monitoring and Surveillance Systems, By Region, 2024-2032 (US$ Mn)
TABLE 15 Global Hospital Infection Prevention and Control Market, by Education and Training Services, By Region, 2019-2023 (US$ Mn)
TABLE 16 Global Hospital Infection Prevention and Control Market, by Education and Training Services, By Region, 2024-2032 (US$ Mn)
TABLE 17 Global Hospital Infection Prevention and Control Market, by Surgical Site Infections (SSIs), By Region, 2019-2023 (US$ Mn)
TABLE 18 Global Hospital Infection Prevention and Control Market, by Surgical Site Infections (SSIs), By Region, 2024-2032 (US$ Mn)
TABLE 19 Global Hospital Infection Prevention and Control Market, by Central Line-Associated Bloodstream Infections (CLABSIs), By Region, 2019-2023 (US$ Mn)
TABLE 20 Global Hospital Infection Prevention and Control Market, by Central Line-Associated Bloodstream Infections (CLABSIs), By Region, 2024-2032 (US$ Mn)
TABLE 21 Global Hospital Infection Prevention and Control Market, by Ventilator-Associated Pneumonia (VAP), By Region, 2019-2023 (US$ Mn)
TABLE 22 Global Hospital Infection Prevention and Control Market, by Ventilator-Associated Pneumonia (VAP), By Region, 2024-2032 (US$ Mn)
TABLE 23 Global Hospital Infection Prevention and Control Market, by Catheter-Associated Urinary Tract Infections (CAUTIs), By Region, 2019-2023 (US$ Mn)
TABLE 24 Global Hospital Infection Prevention and Control Market, by Catheter-Associated Urinary Tract Infections (CAUTIs), By Region, 2024-2032 (US$ Mn)
TABLE 25 Global Hospital Infection Prevention and Control Market, by Clostridioides difficile Infections (CDIs), By Region, 2019-2023 (US$ Mn)
TABLE 26 Global Hospital Infection Prevention and Control Market, by Clostridioides difficile Infections (CDIs), By Region, 2024-2032 (US$ Mn)
TABLE 27 Global Hospital Infection Prevention and Control Market, by Multidrug-Resistant Organisms (MDROs), By Region, 2019-2023 (US$ Mn)
TABLE 28 Global Hospital Infection Prevention and Control Market, by Multidrug-Resistant Organisms (MDROs), By Region, 2024-2032 (US$ Mn)
TABLE 29 Global Hospital Infection Prevention and Control Market, by Hospitals and Clinics, By Region, 2019-2023 (US$ Mn)
TABLE 30 Global Hospital Infection Prevention and Control Market, by Hospitals and Clinics, By Region, 2024-2032 (US$ Mn)
TABLE 31 Global Hospital Infection Prevention and Control Market, by Long-Term Care Facilities, By Region, 2019-2023 (US$ Mn)
TABLE 32 Global Hospital Infection Prevention and Control Market, by Long-Term Care Facilities, By Region, 2024-2032 (US$ Mn)
TABLE 33 Global Hospital Infection Prevention and Control Market, by Ambulatory Surgical Centers, By Region, 2019-2023 (US$ Mn)
TABLE 34 Global Hospital Infection Prevention and Control Market, by Ambulatory Surgical Centers, By Region, 2024-2032 (US$ Mn)
TABLE 35 Global Hospital Infection Prevention and Control Market, by Diagnostic Laboratories, By Region, 2019-2023 (US$ Mn)
TABLE 36 Global Hospital Infection Prevention and Control Market, by Diagnostic Laboratories, By Region, 2024-2032 (US$ Mn)
TABLE 37 Global Hospital Infection Prevention and Control Market, by Pharmaceutical Companies, By Region, 2019-2023 (US$ Mn)
TABLE 38 Global Hospital Infection Prevention and Control Market, by Pharmaceutical Companies, By Region, 2024-2032 (US$ Mn)
TABLE 39 Global Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 40 Global Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 41 Global Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 42 Global Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 43 Global Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 44 Global Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 45 Global Hospital Infection Prevention and Control Market, by Region, 2019-2023 (US$ Mn)
TABLE 46 Global Hospital Infection Prevention and Control Market, by Region, 2024-2032 (US$ Mn)
TABLE 47 North America Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 48 North America Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 49 North America Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 50 North America Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 51 North America Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 52 North America Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 53 North America Hospital Infection Prevention and Control Market, by Country, 2019-2023 (US$ Mn)
TABLE 54 North America Hospital Infection Prevention and Control Market, by Country, 2024-2032 (US$ Mn)
TABLE 55 United States Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 56 United States Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 57 United States Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 58 United States Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 59 United States Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 60 United States Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 61 Canada Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 62 Canada Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 63 Canada Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 64 Canada Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 65 Canada Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 66 Canada Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 67 Mexico Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 68 Mexico Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 69 Mexico Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 70 Mexico Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 71 Mexico Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 72 Mexico Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 73 Europe Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 74 Europe Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 75 Europe Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 76 Europe Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 77 Europe Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 78 Europe Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 79 Europe Hospital Infection Prevention and Control Market, by Country, 2019-2023 (US$ Mn)
TABLE 80 Europe Hospital Infection Prevention and Control Market, by Country, 2024-2032 (US$ Mn)
TABLE 81 Germany Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 82 Germany Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 83 Germany Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 84 Germany Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 85 Germany Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 86 Germany Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 87 France Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 88 France Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 89 France Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 90 France Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 91 France Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 92 France Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 93 United Kingdom Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 94 United Kingdom Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 95 United Kingdom Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 96 United Kingdom Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 97 United Kingdom Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 98 United Kingdom Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 99 Italy Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 100 Italy Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 101 Italy Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 102 Italy Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 103 Italy Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 104 Italy Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 105 Spain Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 106 Spain Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 107 Spain Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 108 Spain Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 109 Spain Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 110 Spain Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 111 Benelux Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 112 Benelux Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 113 Benelux Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 114 Benelux Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 115 Benelux Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 116 Benelux Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 117 Russia Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 118 Russia Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 119 Russia Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 120 Russia Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 121 Russia Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 122 Russia Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 123 Rest of Europe Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 124 Rest of Europe Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 125 Rest of Europe Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 126 Rest of Europe Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 127 Rest of Europe Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 128 Rest of Europe Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 129 Asia Pacific Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 130 Asia Pacific Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 131 Asia Pacific Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 132 Asia Pacific Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 133 Asia Pacific Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 134 Asia Pacific Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 135 China Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 136 China Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 137 China Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 138 China Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 139 China Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 140 China Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 141 Japan Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 142 Japan Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 143 Japan Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 144 Japan Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 145 Japan Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 146 Japan Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 147 India Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 148 India Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 149 India Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 150 India Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 151 India Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 152 India Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 153 South Korea Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 154 South Korea Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 155 South Korea Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 156 South Korea Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 157 South Korea Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 158 South Korea Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 159 South-East Asia Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 160 South-East Asia Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 161 South-East Asia Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 162 South-East Asia Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 163 South-East Asia Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 164 South-East Asia Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 165 Rest of Asia Pacific Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 166 Rest of Asia Pacific Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 167 Rest of Asia Pacific Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 168 Rest of Asia Pacific Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 169 Rest of Asia Pacific Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 170 Rest of Asia Pacific Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 171 Latin America Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 172 Latin America Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 173 Latin America Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 174 Latin America Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 175 Latin America Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 176 Latin America Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 177 Brazil Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 178 Brazil Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 179 Brazil Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 180 Brazil Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 181 Brazil Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 182 Brazil Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 183 Argentina Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 184 Argentina Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 185 Argentina Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 186 Argentina Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 187 Argentina Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 188 Argentina Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 189 Rest of Latin America Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 190 Rest of Latin America Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 191 Rest of Latin America Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 192 Rest of Latin America Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 193 Rest of Latin America Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 194 Rest of Latin America Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 195 Middle East Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 196 Middle East Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 197 Middle East Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 198 Middle East Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 199 Middle East Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 200 Middle East Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 201 UAE Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 202 UAE Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 203 UAE Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 204 UAE Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 205 UAE Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 206 UAE Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 207 Saudi Arabia Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 208 Saudi Arabia Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 209 Saudi Arabia Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 210 Saudi Arabia Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 211 Saudi Arabia Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 212 Saudi Arabia Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 213 Rest of Middle East Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 214 Rest of Middle East Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 215 Rest of Middle East Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 216 Rest of Middle East Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 217 Rest of Middle East Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 218 Rest of Middle East Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 219 Africa Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 220 Africa Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 221 Africa Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 222 Africa Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 223 Africa Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 224 Africa Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 225 South Africa Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 226 South Africa Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 227 South Africa Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 228 South Africa Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 229 South Africa Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 230 South Africa Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 231 Egypt Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 232 Egypt Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 233 Egypt Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 234 Egypt Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 235 Egypt Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 236 Egypt Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)
TABLE 237 Rest of Africa Hospital Infection Prevention and Control Market, by Type of Product, 2019-2023 (US$ Mn)
TABLE 238 Rest of Africa Hospital Infection Prevention and Control Market, by Type of Product, 2024-2032 (US$ Mn)
TABLE 239 Rest of Africa Hospital Infection Prevention and Control Market, by Infection Type, 2019-2023 (US$ Mn)
TABLE 240 Rest of Africa Hospital Infection Prevention and Control Market, by Infection Type, 2024-2032 (US$ Mn)
TABLE 241 Rest of Africa Hospital Infection Prevention and Control Market, by End-User, 2019-2023 (US$ Mn)
TABLE 242 Rest of Africa Hospital Infection Prevention and Control Market, by End-User, 2024-2032 (US$ Mn)

Frequently Asked Questions

What is the current size of the global hospital infection prevention and control market?

The global hospital infection prevention and control market was valued at USD 29541.50 Million in 2023.

What is the expected growth rate of the Hospital Infection Prevention and Control Market between 2024 and 2032?

The Hospital Infection Prevention and Control Market is expected to grow at a CAGR of 7.60% between 2024 and 2032, reaching USD 57114.05 Million in 2032.

Which segment is leading the market share in terms of type of product?

Disinfectants and Sterilization Products is the leading segment by type of product and holds a substantial share in 2023.

Which segment is leading the market share in terms of infection type?

The catheter-associated urinary tract infections (CAUTIs) hold the major share in terms of infection type in value in 2023.

Which segment is expected to post the highest CAGR during the forecast period in terms of End-User?

The Long-Term Care Facilities segment is anticipated to witness substantial growth during the forecast period in terms of End-User.

Which region is dominating the Hospital Infection Prevention and Control Market share?

North America is dominating the hospital infection prevention and control market share, with the highest share in 2023.

Who are the major players in the global hospital infection prevention and control market?

Pfizer Inc., F. Hoffmann-La Roche Ltd (Roche), Merck & Co., Inc., Johnson & Johnson, Abbott, Bayer AG, Becton, Dickinson and Company (BD), Kimberly-Clark Corporation, Nordion, and Cepheid are the prominent players in the hospital infection prevention and control market.

What are the major market drivers of the global hospital infection prevention and control market?

The growth of the Hospital Infection Prevention and Control (HIPC) industry is driven by the increasing prevalence of healthcare-associated infections (HAIs), which result in prolonged hospital stays, higher costs, and elevated mortality rates. Additionally, government regulations and accreditation standards mandating infection control protocols significantly boost market expansion. Furthermore, rising healthcare expenditure, particularly in emerging economies, coupled with the expansion of healthcare facilities and an increase in surgeries, necessitates the implementation of enhanced infection prevention protocols.

What is the major market restraint of the Hospital Infection Prevention and Control Market?

The high cost associated with advanced hospital infection Prevention and Control technologies poses a significant challenge for the market growth. These costs can pose significant barriers, particularly for smaller healthcare facilities and institutions in developing regions with limited financial resources. Consequently, the adoption of comprehensive HIPC measures is often restricted in these settings, impeding the broader implementation of effective infection prevention strategies.

What are the major market opportunities of the global hospital infection prevention and control market?

Technological advancements represent a significant opportunity for innovation and growth in the HIPC market in the future. Technological advancements, including smart disinfection systems, antimicrobial surfaces, and real-time monitoring tools, are revolutionizing infection control in healthcare. These innovations enhance HIPC strategies by offering targeted disinfection, microbial inhibition, and continuous surveillance.

Related Reports By Keyword

Mobile Hospitals Market

Published:
Report ID: 92644

Sports Hospitality Market

Published:
Report ID: 66866

Antimicrobial Hospital Textile Market

Published:
Report ID: 74162

Hospital Bedsheet and Pillow Cover Market

Published:
Report ID: 67774

Hospital Acquired Infection Control Market

Published:
Report ID: 67771

Hospital Workforce Management Market

Published:
Report ID: 67495

Hospital Surgical Disinfectant Market

Published:
Report ID: 67489

Hospital Disinfectant Products and Services Market

Published:
Report ID: 63544

Non-Hospital Based Point-of-Care Diagnostic Products Market

Published:
Report ID: 62461

Related Reports

Thrombolytic Drugs Market

Published:
Report ID: 102009

Bronchitis Treatment Market

Published:
Report ID: 3719

Pharma Grade Glycine Market

Published:
Report ID: 101024

Polymyositis Treatment Market

Published:
Report ID: 9950

Barrett’s Esophagus Market

Published:
Report ID: 55776

Antiepileptic Drugs Market

Published:
Report ID: 48092

Angina Pectoris Treatment Market

Published:
Report ID: 12801

Aseptic Pharma Processing Machinery Market

Published:
Report ID: 99735

Neutropenia Treatment Market

Published:
Report ID: 14460

Vitamin D Therapy Market

Published:
Report ID: 11470

Microvolume Spectrophotometer Market

Published:
Report ID: 99447

Vitamins, Minerals, and Supplements CDMO Market

Published:
Report ID: 99508

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$4699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$5699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$12699

Let us help you

Credence Staff 3

WILLIAM, North America

+1 304 308 1216

Support Staff at Credence Research

KEITH PHILLIPS, Europe

+44 7809 866 263

Lee - CR Sales Staff

LEE VALLANCE, Asia Pacific

+64 22 017 0275

EMAIL US

Request Sample

Smallform of Sample request

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207

support

24/7 Research Support

sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

Get Methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN

Request Sample